Sugawara Kenji

Affiliation and department：
Research theme for competitive and other funds (13)：

2023 - 2026 Elucidation of the molecular mechanism and physiological significance of retrograde glucose transport in the intestine.
2022 - 2024 メトホルミンが生体内の金属動態に与える影響およびその意義の解明
2021 - 2024 メトホルミンによる腸管腔内へのグルコース排泄機構の解明
2022 - 2023 消化管における逆行性グルコース輸送機構の包括的解析
2020 - 2023 鉄キレート作用を介したメトホルミンによる新規耐糖能改善メカニズムの解明

Show all

Papers (23)：

Quan Yingyue, Kenji Sugawara, Harumi Takahashi, Norihide Yokoi, Kento Ohbayashi, Yusaku Iwasaki, Susumu Seino, Wataru Ogawa. Stimulatory effect of imeglimin on incretin secretion. Journal of diabetes investigation. 2023. 14. 6. 746-755
Kyosuke Sato, Kenji Sugawara, Wataru Ogawa. A novel view of the insulin signaling pathway based on prediction of protein structure by the AI platform AlphaFold. Journal of diabetes investigation. 2023
Kaori Hozumi, Kenji Sugawara, Takaya Ishihara, Naotada Ishihara, Wataru Ogawa. Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes. Scientific reports. 2023. 13. 1. 746-746
Kenji Sugawara, Wataru Ogawa. New mechanism of metformin action mediated by lysosomal presenilin enhancer 2. Journal of diabetes investigation. 2022
Kei Yoshino, Yushi Hirota, Wataru Ogawa, Kenji Sugawara, Akira Kawaguchi, Hiroshi Yoshino, Midori Ishibashi, Gen Yoshino, Masafumi Koga. A case of α-chain variant hemoglobin (Hb Chad) with falsely high HbA1c levels measured by immunoassay. Diabetology international. 2022. 13. 1. 330-335

ｍore...

MISC (90)：

森田靖子, 坂口一彦, 野上宗伸, 曽菲比, 西坂まり華, 末松那都, 山田倫子, 細川友誠, 菅原健二, 廣田勇士, et al. 糖代謝制御機構における消化管グルコース排泄の意義についての解析. 糖尿病. 2024. 67. Suppl.1. S-157
小川渉, 森田靖子, 細川友誠, 菅原健二, 坂口一彦. 腸内環境とSugar:health and disease メトホルミンが制御する腸管内腔へのグルコース排出(Gut and sugar: health and disease Metformin-regulated glucose excretion into the intestinal lumen). 糖尿病. 2024. 67. Suppl.1. S-33
穂積かおり, 平田悠, 菅原健二, 内山奏, 井上朋也, 安立原, 西垣智子, 野村和弘, 小川渉. 骨格筋を中心とした組織間ネットワーク腸管骨格筋相互作用による筋量制御のメカニズム. 糖尿病. 2024. 67. Suppl.1. S-59
菅原健二. 腸管へのグルコース排泄による新規糖代謝制御機構の解明. 医科学応用研究財団研究報告. 2024. 41. 464-466
菅原健二. 腸管へのグルコース排泄による新規糖代謝制御機構の解明. 医科学応用研究財団研究報告(CD-ROM). 2024. 41

ｍore...

Patents (1)：

Books (6)：

ｍore...

Lectures and oral presentations (15)：

Myofiber Piezo1 regulates muscle hypertrophy and metabolism in response to exercise
(60th EASD Annual Meeting of the European Association for the Study of Diabetes (Madrid, Spain) 2024)
Similarity and difference of intestinal actions of metformin and imeglimin
(59th EASD Annual Meeting)
Effects of Imeglimin on Mitochondrial Function, AMPK Activation, and Gene Expression in Hepatocytes and Myocytes
(The 50th European Muscle Conference)
Quantitative analysis of metformin-induced glucose excretion in the intestine
(The 83rd American Diabetes Association Scientific Sessions.)
Chronic arsenic exposure impairs pancreatic beta cell function.
(Society of Environmental Toxicology and Chemistry Conference (Brussel, Belgium) 2017)

ｍore...

Professional career (1)：

Awards (2)：

Association Membership(s) (4)：

THE JAPANESE SOCIETY OF INTERNAL MEDICINE , The Japan Endocrine Society , THE JAPAN DIABETES SOCIETY , アジア糖尿病学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page